您的位置: 首页 > 农业专利 > 详情页

Fatty acid derivatives with high palatability for oral administration
专利权人:
CORUZZO, ANNA;BERNI CANANI, ROBERTO;MAZZONI, ORIETTA (EREDI);CALIGNANO, ANTONIO
发明人:
BERNI CANANI, ROBERTO,CALIGNANO, ANTONIO,MAZZONI, ORIETTA (EREDI),CORUZZO, ANNA
申请号:
ES09734632
公开号:
ES2498681T3
申请日:
2009.04.21
申请国别(地区):
ES
年份:
2014
代理人:
摘要:
Derivative selected from the group of compounds having the following formula: N- (1-carbamoyl-2-phenyl-ethyl) butyramide; N- (1-Butyroyl-carbamoyl-2-phenyl-ethyl) butyramide; 5-benzyl-2-propyl-1H-imidazol-4 (5H) -one; N- (1-oxo-3-phenyl-1- (piperidin-1-yl) propan-2-yl) butyramide; N- (1-oxo-3-phenyl-1- (pyrrolidin-1-yl) propan-2-yl) butyramide; N- (1- (methylcarbamoyl) -2-phenylethyl) butyramide; N- (1- (ethylcarbamoyl) -2-phenylethyl) butyramide; N- (1- (propylcarbamoyl) -2-phenylethyl) butyramide; N- (1- (butylcarbamoyl) -2-phenylethyl) butyramide; N- (1- (pentylcarbamoyl) -2-phenylethyl) butyramide; N- (1-carbamoyl-2-phenylethyl) -N-methylbutyramide; N- (1-carbamoyl-2-phenylethyl) -N-ethylbutyramide; - (1-carbamoyl-2-phenylethyl) -N-propylbutyramide; corresponding mixtures and corresponding salts of pharmaceutically acceptable bases or acids, diastereoisomeric forms and pure enantiomeric forms or mixtures thereof.Derivado seleccionado de entre el grupo de compuestos que tienen la fórmula siguiente: N-(1-carbamoil-2-fenil-etil)butiramida; N-(1-butiroil-carbamoil-2-fenil-etil)butiramida; 5-bencil-2-propil-1H-imidazol-4(5H)-ona; N-(1-oxo-3-fenil-1-(piperidin-1-il)propan-2-il)butiramida; N-(1-oxo-3-fenil-1-(pirrolidin-1-il)propan-2-il)butiramida; N-(1-(metilcarbamoil)-2-feniletil)butiramida; N-(1-(etilcarbamoil)-2-feniletil)butiramida; N-(1-(propilcarbamoil)-2-feniletil)butiramida; N-(1-(butilcarbamoil)-2-feniletil)butiramida; N-(1-(pentilcarbamoil)-2-feniletil)butiramida; N-(1-carbamoil-2-feniletil)-N-metilbutiramida; N-(1-carbamoil-2-feniletil)-N-etilbutiramida; -(1-carbamoil-2-feniletil)-N-propilbutiramida; mezclas correspondientes y sales correspondientes de las bases o ácidos farmacéuticamente aceptables, formas diastereoisoméricas y formas enantioméricas puras o sus mezclas.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充